Waldencast PLC (NASDAQ:WALD – Get Free Report) saw a significant decline in short interest during the month of August. As of August 14th, there was short interest totaling 58,897 shares, a decline of 79.2% from the July 30th total of 282,629 shares. Based on an average trading volume of 225,077 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.0% of the shares of the stock are sold short.
Wall Street Analysts Forecast Growth
WALD has been the topic of several recent analyst reports. Weiss Ratings raised shares of Waldencast from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, August 17th. Wall Street Zen upgraded Waldencast to a “hold” rating in a report on Saturday, May 30th. Finally, Canaccord Genuity Group boosted their price objective on shares of Waldencast from $2.00 to $3.00 and gave the stock a “buy” rating in a research note on Tuesday, June 2nd. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Waldencast presently has a consensus rating of “Hold” and a consensus target price of $2.33.
Read Our Latest Analysis on WALD
Hedge Funds Weigh In On Waldencast
Waldencast Trading Down 0.7%
Shares of Waldencast stock traded down $0.01 during trading hours on Thursday, hitting $1.36. 43,657 shares of the company’s stock traded hands, compared to its average volume of 300,454. Waldencast has a twelve month low of $0.72 and a twelve month high of $3.22. The company has a quick ratio of 0.97, a current ratio of 1.70 and a debt-to-equity ratio of 0.29. The stock has a 50 day simple moving average of $1.57 and a 200-day simple moving average of $1.46.
Waldencast Company Profile
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners.
Featured Stories
- Five stocks we like better than Waldencast
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.
